These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27929253)

  • 1. Amiodarone for the Prevention of Sudden Cardiac Death.
    Saguil A
    Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination ICD and drug treatments-best options.
    Dorian P
    Resuscitation; 2000 Aug; 45(3):S3-6. PubMed ID: 10959027
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
    Domanski MJ
    J Interv Cardiol; 1995 Feb; 8(1):9-15. PubMed ID: 10155222
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-threatening arrhythmias and therapy.
    Myerburg RJ
    Resuscitation; 2000 Aug; 45(3):S1-2. PubMed ID: 10959026
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden death due to cardiac arrhythmias.
    Huikuri HV; Castellanos A; Myerburg RJ
    N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical therapy for arrhythmias and EBM].
    Otsuka T; Yamashita T
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):234-9. PubMed ID: 16536072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arrhythmias in cardiomyopathies].
    Kaneko Y; Kurabayashi M
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trials: how long should they last?
    Wellens HJ
    Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lethal arrhythmia associated with heart failure].
    Shiga T; Hagiwara N; Kasanuki H
    Nihon Rinsho; 2007 May; 65 Suppl 5():364-8. PubMed ID: 17571407
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden cardiac death: prevention and treatment.
    Kwok KM; Lee KL; Lau CP; Tse HF
    Hong Kong Med J; 2003 Oct; 9(5):357-62. PubMed ID: 14530531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 13. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental principle in therapy for arrhythmia].
    Atarashi H
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):228-33. PubMed ID: 16536071
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of amiodarone in the era of the implantable cardioverter defibrillator.
    Dorian P; Mangat I
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S78-81. PubMed ID: 12950525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are implantable cardioverter-defribrillators always superior to amiodarone?
    Doggrell SA
    Expert Opin Pharmacother; 2003 Nov; 4(11):2111-4. PubMed ID: 14596664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent trends in anti-arrhythmia therapy].
    Ogawa S
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):439-41. PubMed ID: 7751785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amiodarone or ICD in patients with cardiac insufficiency. SCD-HeFT Study].
    Borggrefe M; Wolpert C
    Internist (Berl); 2006 Jan; 47(1):89-91. PubMed ID: 16344952
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: is there a role for amiodarone?
    Prasad K; Frenneaux MP
    Heart; 1998 Apr; 79(4):317-8. PubMed ID: 9616334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.